Links Between Perception of Temporal Order Judgment and Causality in Schizophrenia
NCT ID: NCT03432000
Last Updated: 2025-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
52 participants
INTERVENTIONAL
2018-02-01
2022-05-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Time Windows in Patients With Schizophrenia and Healthy Controls
NCT00350805
Future Mental Projections in Schizophrenia
NCT03040505
Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia
NCT06361407
Sustained Attention Abilities in Schizophrenia
NCT02388607
Involuntary Memories Investigation in Schizophrenia
NCT03209778
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To carry out this work, the investigators will rely on an experimental paradigm (derived from Michotte's paradigm) which makes it possible to explore the links between temporal sequencing and perception of causality, validated in the normal subject. subjective consequences of these alterations will be explored using a phenomenological-inspired clinical scale (EAWE time-scale items)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
* evaluate the links (correlation) between perception of temporal sequencing and perception of causality using an adapted experimental paradigm (Michotte paradigm) and to compare performance between healthy subjects and controls
* investigate the existence of a correlation between these alterations and the peculiarities of the subjective experience of time (EAWE scale) in the group of subjects with schizophrenia
The measures that will be realized are:
* Performances of patients and controls on temporal task
* Subjective alterations of time perception in patients with an adapted scale (EAWE)
* Global symptomatology with PANSS (positive and negative symptom scale)
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subjects with schizophrenia
Performances on temporal task Subjective alterations of time perception in patients with an adapted scale (EAWE) Global symptomatology with PANSS (positive and negative symptom scale)
Performances of patients and controls on temporal task
To carry out this work, we will rely on an experimental paradigm (derived from Michotte's paradigm) which makes it possible to explore the links between temporal sequencing and perception of causality, validated in the normal subject. subjective consequences of these alterations will be explored using a phenomenological-inspired clinical scale (EAWE time-scale items)
healthy subjects
Evaluate the links (correlation) between perception of temporal sequencing and perception of causality using an adapted experimental paradigm (Michotte paradigm) and to compare performance between healthy subjects and controls Investigate the existence of a correlation between these alterations and the peculiarities of the subjective experience of time (EAWE scale) in the group of subjects with schizophrenia
Performances of patients and controls on temporal task
To carry out this work, we will rely on an experimental paradigm (derived from Michotte's paradigm) which makes it possible to explore the links between temporal sequencing and perception of causality, validated in the normal subject. subjective consequences of these alterations will be explored using a phenomenological-inspired clinical scale (EAWE time-scale items)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Performances of patients and controls on temporal task
To carry out this work, we will rely on an experimental paradigm (derived from Michotte's paradigm) which makes it possible to explore the links between temporal sequencing and perception of causality, validated in the normal subject. subjective consequences of these alterations will be explored using a phenomenological-inspired clinical scale (EAWE time-scale items)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age from 18 to 45 years
* Diagnosis of schizophrenia according to DSM V criteria
* French mother tongue
* Psychotropic treatment unchanged during the month preceding the inclusion
* Stable symptomatology
* Normal or corrected visual acuity (\> 0.8 at Snellen scale) and normal color vision
* Patients who gave informed consent to participate in the study
Control subjects (healthy volunteers):
* Age from 18 to 45 years
* Absence of neurological and psychiatric disorders
* French mother tongue
Exclusion Criteria
* Neurological disorders of vascular, infectious or neurodegenerative origin
* Taking somatic drugs with a cerebral or mental impact (eg corticosteroids)
* Disabling sensory disturbances, and in particular visual acuity
* Participation in a Neuro Cognitive Remediation Program
* Schizophrenia resistant to neuroleptic treatments
* Persons protected by law (pregnant women, minors, major under guardianship ...)
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital le Vinatier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MARTIN BRICE
Role: PRINCIPAL_INVESTIGATOR
CH LE VINATIER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vial Veronique
Bron, Auvergne-Rhône-Alpes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A03019-44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.